MYCN and neuroblastoma: Therefore, in accordance with previous findings on high-risk NB patients [28,30], age ≥ 18 months and LDH ≥ 1400 U/L were confirmed as representative strong high-risk markers in stage 4, MYCN non-amplified cases.